CNBX PHARMACEUTICALS INC. Payments to Acquire Available-for-sale Securities
CNBX PHARMACEUTICALS INC. (CNBX) reported Payments to Acquire Available-for-sale Securities of $0 for the 12-month period ending 2020-08-31, per its 10-K filed 2020-11-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2020-11-04
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for the quarter ending 2020-08-31 was $0.00.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for the quarter ending 2020-05-31 was $0.00.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for the quarter ending 2020-02-29 was $0.00, a 100.00% decline year-over-year.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for the quarter ending 2019-11-30 was $0.00, a 100.00% decline year-over-year.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for fiscal 2019 was $1.92M.
- CNBX PHARMACEUTICALS INC. payments to acquire available-for-sale securities for fiscal 2018 was $0.00.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 9 month as first filed | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|---|
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $0.00 derived: sum of 3 quarters · filed 2020-11-04 | $0.00 10-K · filed 2020-11-04 | |
| 2020-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-14 | $0.00 derived: sum of 2 quarters · filed 2020-07-14 | $0.00 10-Q · filed 2020-07-14 | $0.00 derived: sum of 4 quarters · filed 2020-11-04 | |
| 2020-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $0.00 10-Q · filed 2020-04-13 | $0.00 derived: sum of 3 quarters · filed 2020-11-04 | $0.00 derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-11-30 | $0.00 10-Q · filed 2020-01-14 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $0.00 derived: sum of 3 quarters · filed 2020-11-04 | $700.00K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $700.00K derived: sum of 3 quarters · filed 2020-11-04 | $1.92M 10-K · filed 2020-11-04 | |
| 2019-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-14 | $700.00K derived: sum of 2 quarters · filed 2020-07-14 | $1.92M 10-Q · filed 2020-07-14 | $3.79M 10-Q · filed 2019-07-15 | $1.92M derived: sum of 4 quarters · filed 2020-07-14 |
| 2019-02-28 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $1.92M 10-Q · filed 2020-04-13 | $1.92M derived: sum of 3 quarters · filed 2020-04-13 | ||
| 2018-11-30 | $1.22M 10-Q · filed 2020-01-14 | $1.22M derived: sum of 2 quarters · filed 2020-01-14 | |||
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-29 | $0.00 10-K · filed 2019-11-29 | |||
| 2018-05-31 | $0.00 10-Q · filed 2019-07-15 |